Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2013


Pharmaceutical Microbiology

30 Jan 2013 - 31 Jan 2013 - London, UK



Bookmark and Share


Book by 28th September and receive a £300 discount

Visit www.pharma-microbiology.com to claim your discount now!

Don’t miss SMi’s 2nd annual Pharmaceutical Microbiology conference that aims to provide an expert and highly accredited speaker line up including 13 pharma speakers who will focus on the latest developments and procedures used in the identification and prevention of contaminating agents, updates on new rules and regulations and the challenges facing the Pharmaceutical Microbiology industry. 

Reasons you should not miss this incredible event includes:

Discuss developments in tools, techniques and procedures used in identification and control of contaminants

Evaluate the handling of traditional drug and biologics & sterile product manufacturing 

Hear about design, construction and validation of sterile facilities and equipment

Engage with those currently working on producing the rapid microbial methods

Key Speakers include:

Oliver Chancel, Microbiologist, Sanofi-Aventis

Kim Bowers, Senior Scientist, Pfizer

Praful Bhusari, Associate Scientist, MedImmune

John Duguid, Principle Analytical Scientist, Genzyme

Scott Smith, Microbiology Team Leader, Sanofi-Aventis

Anne Warford, Associate Director, MedImmune

Amy McDaniel, Director, QC Microbiology, Pfizer

Stephen Rawling, Microbiology Team Leader, GlaxoSmithKline

Brendan Gilmore, Research Scientist, Queens University Belfast

Andrew Bartko, Senior Scientist, Battelle Research Institute

Hilary Chan, Quality Scientist IV, Pfizer  

Mark Thompson, Consultant, EPIC Consultancy & Training

Daniel Kockelkorn, Head of PKau Laboratory, Roche 

Emiliano Toso, Principle Scientist, Merck 

Gunther Meike, System Development Specialist, Charles River Laboratories

For more information contact Farhaana Rahman on +44 0 207 827 6186 or email frahman@smi-online.co.uk 



Further information
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Computerized Flexible Needles Prove Themselves in Biological Tissue
The advantage of the system is that you can avoid obstacles with the needles or critical tissues and that the system during the insertion of the needle in real time can adjust the path if, for example, the tissue deforms.
DARWIN 2 24-week Monotherapy Data in RA Confirm Previous Results
Safety profile in DARWIN 2 consistent with previous filgotinib RA studies.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
Overdose of Vitamin D in Teenagers May Lead to Increased Cholesterol Levels
Dosing obese teens with vitamin D shows no benefits for their heart health or diabetes risk, and could have the unintended consequences of increasing cholesterol and fat-storing triglycerides. These are the latest findings in a series of Mayo Clinic studies in childhood obesity.
Phase 2 Trials Underway for New Single Dose Malaria Treatment
The new drug, which prevents the malaria parasite from reproducing and spreading, is now undergoing Phase II clinical trials in humans.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!